Calvin DC - Search Results

1

Nitric oxide-dependent penile erection in mice lacking neuronal nitric oxide synthase.

Burnett AL, Nelson RJ, Calvin DC, Liu JX, Demas GE, Klein SL, Kriegsfeld LJ, Dawson VL, Dawson TM, Snyder SH. Burnett AL, et al. Among authors: calvin dc. Mol Med. 1996 May;2(3):288-96. Mol Med. 1996. PMID: 8784782 Free PMC article.

2

Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans.

Burnett AL, Calvin DC, Chamness SL, Liu JX, Nelson RJ, Klein SL, Dawson VL, Dawson TM, Snyder SH. Burnett AL, et al. Among authors: calvin dc. Nat Med. 1997 May;3(5):571-4. doi: 10.1038/nm0597-571. Nat Med. 1997. PMID: 9142130

3

Immunohistochemical description of nitric oxide synthase isoforms in human clitoris.

Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Burnett AL, et al. Among authors: calvin dc. J Urol. 1997 Jul;158(1):75-8. doi: 10.1097/00005392-199707000-00020. J Urol. 1997. PMID: 9186326 Free article.

4

Ejaculatory abnormalities in mice with targeted disruption of the gene for heme oxygenase-2.

Burnett AL, Johns DG, Kriegsfeld LJ, Klein SL, Calvin DC, Demas GE, Schramm LP, Tonegawa S, Nelson RJ, Snyder SH, Poss KD. Burnett AL, et al. Among authors: calvin dc. Nat Med. 1998 Jan;4(1):84-7. doi: 10.1038/nm0198-084. Nat Med. 1998. PMID: 9427611

5

Characterization of the enzymatic activity of PSM: comparison with brain NAALADase.

Tiffany CW, Lapidus RG, Merion A, Calvin DC, Slusher BS. Tiffany CW, et al. Among authors: calvin dc. Prostate. 1999 Apr 1;39(1):28-35. doi: 10.1002/(sici)1097-0045(19990401)39:1<28::aid-pros5>3.0.co;2-a. Prostate. 1999. PMID: 10221263

6

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease.

Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al. Shull MM, et al. Nature. 1992 Oct 22;359(6397):693-9. doi: 10.1038/359693a0. Nature. 1992. PMID: 1436033 Free PMC article.

7

Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.

Thomas AG, Wozniak KM, Tsukamoto T, Calvin D, Wu Y, Rojas C, Vornov J, Slusher BS. Thomas AG, et al. Adv Exp Med Biol. 2006;576:327-37; discussion 361-3. doi: 10.1007/0-387-30172-0_24. Adv Exp Med Biol. 2006. PMID: 16802724 Review.

8

Enantiospecificity of glutamate carboxypeptidase II inhibition.

Tsukamoto T, Majer P, Vitharana D, Ni C, Hin B, Lu XC, Thomas AG, Wozniak KM, Calvin DC, Wu Y, Slusher BS, Scarpetti D, Bonneville GW. Tsukamoto T, et al. Among authors: calvin dc. J Med Chem. 2005 Apr 7;48(7):2319-24. doi: 10.1021/jm049258g. J Med Chem. 2005. PMID: 15801825

9

Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.

Tentori L, Leonetti C, Scarsella M, Vergati M, Xu W, Calvin D, Morgan L, Tang Z, Woznizk K, Alemu C, Hoover R, Lapidus R, Zhang J, Graziani G. Tentori L, et al. Int J Oncol. 2005 Feb;26(2):415-22. Int J Oncol. 2005. PMID: 15645126

10

Ketopyrrolidines and ketoazetidines as potent dipeptidyl peptidase IV (DPP IV) inhibitors.

Ferraris D, Ko YS, Calvin D, Chiou T, Lautar S, Thomas B, Wozniak K, Rojas C, Kalish V, Belyakov S. Ferraris D, et al. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5579-83. doi: 10.1016/j.bmcl.2004.08.057. Bioorg Med Chem Lett. 2004. PMID: 15482928

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters